Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Kodama H, Kadowaki S, Ishizuka Y, Wakabayashi M, Sakakida T, Honda K, Masuishi T, Narita Y, Taniguchi H, Ando M, Kishikawa T, Terada H, Beppu S, Nishikawa D, Suzuki H, Hanai N, Muro K.
Kodama H, et al. Among authors: ando m.
Int J Clin Oncol. 2025 Jan 14. doi: 10.1007/s10147-025-02698-1. Online ahead of print.
Int J Clin Oncol. 2025.
PMID: 39806030